What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the estimated listing price for Indegene Limited IPO?

Based on the upper price band of ₹452 and current GMP of ₹275, the estimated listing price is ₹727 (approx. 60.8% gain).

What is the expected profit per lot for Indegene Limited IPO?

With a lot size of 33 shares and current GMP of ₹275, expected profit per retail application lot is approximately ₹9,075.

IPO GreyPremiumLIVE

Grey Market Intelligence

Indegene Limited

ListedMainboard

Healthcare / Life Sciences · NSE / BSE

Founded in 1998, Indegene Limited is a leading digital solutions provider for the life sciences industry, helping companies with everything from drug development and clinical trials to regulatory submissions and sales & marketing. The company offers a wide range of services through its Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical Solutions, and Enterprise Clinical Solutions, along with expert consultancy. Its subsidiary, DT Consulting, specializes in guiding life sciences firms through digital transformation to enhance customer experiences. Indegene has also been recognized for its workplace excellence, winning the Platinum Level award at the 2023 Healthy Workplace Conference and Awards. With a global team of 5,181 professionals and 65 active clients across India, North America, Europe, China, and beyond, Indegene continues to deliver innovative and impactful solutions for the life sciences sector.

Price Band

₹430 – ₹452

Issue Size

₹1842 Cr

Lot Size

33 shares

GMP

₹275

+60.8%

Est. Listing

₹727

at current GMP

Subscribed

70.26x

overall

Open

6 May 2024

8 May 2024

Allotment

10 May 2024

Refund

11 May 2024

Demat Credit

12 May 2024

Listing

13 May 2024

Last updated 12 days ago

Overview Live GMP Live Subscription Allotment Status

Live Grey Market Premium

Indegene Limited GMP Today

Last updated: 19 Oct 2026

Current Premium

₹275+60.8%

Issue Price (Upper)

₹452

Band: ₹430 – ₹452

Estimated Listing Price

₹727

Upper price + GMP

Lot Size

33 shares

Min investment ₹14,916

Estimated Profit / Lot

Date	GMP (₹)	GMP %	Est. Listing
31 Oct 2026	+₹275	60.8%	₹727
30 Oct 2026	+₹275	60.8%	₹727
29 Oct 2026	+₹248	54.8%	₹700

About Indegene Limited Public Issue & Market Profile

Indegene Limited is bringing an initial public offering (IPO) in the Healthcare / Life Sciences sector with an aggregate issue size of ₹1,841.76 Crores. The shares are offered at a price band of ₹430 to ₹452 per equity share on NSE and BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.

Public Issue & Pricing Context:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 33 shares (approx. ₹14,916 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Basis of Allotment & Listing Timeline:

Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2024-05-12, while un-allotted funds or UPI block mandates will be released on 2024-05-11.

Frequently Asked Questions

What is Indegene Limited IPO GMP today?

The latest grey market premium for Indegene Limited IPO is ₹275, which indicates an expected listing price of ₹727.

What does Kostak Rate and Sauda mean in IPO GMP?

Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.

Is Grey Market Premium officially recognized?

No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.